Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02390791 · ClinicalTrials.gov registry record · NA

New Technologies to Help Manage ADHD

A NA study of Attention Deficit Hyperactivity Disorder, sponsored by Children's Hospital Medical Center, Cincinnati.

Completed
Registry status
NA
Development phase
85
Enrollment target
1
Study location

NCT02390791 is a NA study of Attention Deficit Hyperactivity Disorder that has completed, run by Children's Hospital Medical Center, Cincinnati. The registered enrollment target is 85 participants, below the 206-participant average among 88 other Attention Deficit Hyperactivity Disorder trials with a reported enrollment target (59% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02390791, a NA study of Attention Deficit Hyperactivity Disorder, has completed, sponsored by Children's Hospital Medical Center, Cincinnati.

COMPLETED
Registry status
NA
Development phase
85 participants
Enrollment target
1
Study location

Study Summary

Cluster randomized controlled trial to evaluate the general effectiveness of intervention compared to control on medication continuity as measured by prescriptions written and other more proximal outcomes during the first six months of treatment.

Interventions

  • OTHER enhanced myADHDportal.com
  • OTHER treatment as usual standard portal

Study Locations (1)

Ohio

  • William B Brinkman - Cincinnati

Trial Details

FieldValue
Enrollment Target 85 participants
Start Date 2015-09
Est. Completion 2017-08
Phase NA

What the Registry Record Tells You About NCT02390791

The ClinicalTrials.gov registry entry for NCT02390791 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 85 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 206-participant average among 88 other Attention Deficit Hyperactivity Disorder trials with a reported enrollment target (59% lower). The listed sponsor is Children's Hospital Medical Center, Cincinnati, which has 571 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Attention Deficit Hyperactivity Disorder appearing as the primary indexed condition, and to 2 interventions - of which enhanced myADHDportal.com is the first listed.

NCT02390791 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.

Frequently Asked Questions

What is clinical trial NCT02390791 about?

NCT02390791 is a clinical study titled "New Technologies to Help Manage ADHD". Cluster randomized controlled trial to evaluate the general effectiveness of intervention compared to control on medication continuity as measured by prescriptions written and other more proximal outcomes during the first six months of treatment.

What is the current status of trial NCT02390791?

This trial is currently completed. It is a NA study. The enrollment target is 85 participants. The study started on 2015-09. Estimated completion is 2017-08.

What conditions does trial NCT02390791 study?

This clinical trial studies the following conditions: Attention Deficit Hyperactivity Disorder.

What interventions are being tested in trial NCT02390791?

The interventions under investigation include: enhanced myADHDportal.com (OTHER), treatment as usual standard portal (OTHER).

Who is sponsoring clinical trial NCT02390791?

This trial is sponsored by Children's Hospital Medical Center, Cincinnati, which has 571 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02390791 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Attention Deficit Hyperactivity Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.